Gastrointestinal Therapeutics Market: How Is Gastroparesis Pharmacotherapy Advancing?
Gastroparesis — delayed gastric emptying causing chronic nausea, vomiting, and early satiety — has historically had very limited pharmacological treatment options, with the Gastrointestinal Therapeutics Market reflecting the anticipated entry of relamorelin and trazpiroben as potential first new gastroparesis pharmacological approvals in decades that could transform management of...
0 Комментарии 0 Поделились 13 Просмотры 0 предпросмотр